Key result
Mepolizumab normalizes eosinophils to rescue a patient with steroid-refractory hypereosinophilic syndrome and fulminant myocarditis.
Why the study?
Hypereosinophilic syndrome is a rare hematologic disorder with multiorgan involvement, and its most lethal form, Loeffler endomyocarditis, often results in fatal cardiac or embolic events.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
In steroid-refractory hypereosinophilic syndrome with myocarditis, CMR is superior to echocardiography for detecting thrombi, and mepolizumab is an effective rescue therapy.
BACKGROUND: Hypereosinophilic syndrome is a rare hematologic disorder with multiorgan involvement. Its most lethal form, Loeffler endomyocarditis, often results in fatal cardiac or embolic events. CASE SUMMARY: /L, and a peak troponin of 47,000 ng/L. She developed acute encephalopathy from a cardioembolic storm and eosinophilic pleocytosis. Although echocardiography was inconclusive, cardiac magnetic resonance (CMR) identified a large laminar thrombus and subendocardial necrosis. Despite pulse-dose steroids and hydroxyurea, she suffered a hematologic relapse. Initiation of mepolizumab (anti-interleukin-5) led to rapid eosinophil normalization and clinical recovery. DISCUSSION: This case highlights the diagnostic superiority of CMR over echocardiography for detecting laminar thrombi. It illustrates the limitations of steroids in suppressing the myeloproliferative drive and demonstrates mepolizumab's efficacy as an acute rescue therapy. TAKE-HOME MESSAGES: CMR is mandatory in suspected eosinophilic myocarditis when echocardiography is negative. In steroid-refractory hypereosinophilic syndrome, early interleukin-5 inhibition is a life-saving intervention.
No takes yet. Share an insight, caveat, or question.
Althobaiti et al. (2026) conducted a case report in Fulminant Eosinophilic Myocarditis in Steroid-Refractory Hypereosinophilic Syndrome (n=1). Mepolizumab was evaluated on Eosinophil normalization and clinical recovery. Initiation of mepolizumab led to rapid eosinophil normalization and clinical recovery in a patient with steroid-refractory hypereosinophilic syndrome and fulminant myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: